ASH HIGHLIGHTS 2024 – LYMPHOMA ROUNDTABLE DISCUSSIONS: ECOG-ACRIN EA4151 Phase 3 Randomized Trial

OR
Please enter your username or email address. You will receive an email message to log in.
Explore more from your favourite experts – click their name to access their entire library of content.

Chair

Speaker
This program has been made possible through unrestricted support from BeiGene, Eli Lilly & Pfizer